Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,420 public trials 2,005 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, not recruiting

A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

NCT05889988

Conditions
Breast Diseases, Breast Neoplasm, Breast Neoplasms, +7 more
Locations
  • Riverwood Healthcare Center Aitkin, Minnesota, United States
  • Essentia Health Baxter Clinic Baxter, Minnesota, United States
  • Essentia Health Saint Joseph's Medical Center Brainerd, Minnesota, United States
  • Essentia Health - Deer River Clinic Deer River, Minnesota, United States
View all 21 locations
View Trial Details
Active, not recruiting

Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC

NCT04565054

Conditions
Breast Cancer Female, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Praxis für interdisziplinäre Onkologie & Hämatologie Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • SLK Kliniken Heilbronn Klinik für Gynäkologie und Geburtshilfe Heilbronn, Baden-Wurttemberg, Germany
  • MVZ für Hämatologie und Onkologie Ravensburg, Baden-Wurttemberg, Germany
  • Universitätsklinikum Ulm Frauenheilkunde, Geburtshilfe Ulm, Baden-Wurttemberg, Germany
View all 85 locations
View Trial Details
Active, not recruiting

MARGetuximab Or Trastuzumab (MARGOT)

NCT04425018

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 14 locations
View Trial Details
Active, not recruiting

DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer

NCT04042701

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Univ. of Cali. San Francisco Medical Center San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Cancer Specialists of North Florida (Cbo) Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details
Active, not recruiting

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

NCT04180371

Conditions
Adnexal Diseases, Advanced Solid Tumor Historically Known for High EphA2 Expression, Breast Diseases, +49 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. Encinitas, California, United States
  • University of California - Irvine Medical Center Orange, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 28 locations
View Trial Details

Related conditions